SPONSOR
Pierre Fabre Medicament
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2
Conditions studied: Advanced Breast CancerNon-Small Cell Lung CancerNSCLCEGFR/HER2 Exon 20 Insertion Mutation
NCT06500494
Recruiting
To Describe How Well Vinorelbine Given Orally Works in Patients With a Breast Cancer After 2 Years of Treatment
Advanced Breast Cancer
NCT06043817 Phase 1, Phase 2
Recruiting
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
Non-Small Cell Lung Cancer